Through focused collaboration with The Chase Group, Biologics Consulting has entered a season of growth by successfully placing, in a newly created position, a Director, CMC Business Lead. A subject matter expert and experienced leader, the Director is responsible for furthering the development of the CMC consulting team by driving business development, financial performance, and market expansion of the group. The cornerstone of the success at Biologics Consulting is found in their team of consultants and professional services staff, and this critical hire will make an impact on the future success of the company. The Chase Group values our partnership as we work to identify the high caliber talent required for Biologics Consulting to continue building upon their unprecedented record of achievement. For questions on partnering with The Chase Group to build your leadership team, please contact ken@chasegroup.com.
Biologics Consulting Leadership Team Grows Through Partnership with The Chase Group
Through focused collaboration with The Chase Group, Biologics Consulting has entered a season of growth by successfully placing, in a newly created position, a Director, CMC Business Lead. A subject matter expert and experienced leader, the Director is responsible for furthering the development of the CMC consulting team by driving business development, financial performance, and market expansion of the group. The cornerstone of the success at Biologics Consulting is found in their team of consultants and professional services staff, and this critical hire will make an impact on the future success of the company. The Chase Group values our partnership as we work to identify the high caliber talent required for Biologics Consulting to continue building upon their unprecedented record of achievement. For questions on partnering with The Chase Group to build your leadership team, please contact ken@chasegroup.com.- Categories: Life Sciences
The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals
Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience….
The Chase Group Successfully Places David Geller, MD as Head of Pulmonary & Rare Disease Clinical Development for Arcturus Therapeutics
The Chase Group (TCG) is pleased to announce the successful recruitment of David Geller, MD as the Vice President, Pulmonary and Rare Diseases Clinical Development…
Drug Safety Leadership Team Grows at Ionis Pharmaceuticals Through Continued Partnership with The Chase Group
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually…
The Chase Group Continues Successful Collaboration with Genmab Through Placement of Vice President, CDTL
The Chase Group, known for its thorough search capabilities and expertise in Life Sciences Executive Search, was retained by Genmab Pharmaceuticals to execute a critical…
The Chase Group Successfully Secures Vice President, Head of Medical Development for Checkmate Pharmaceuticals
Building on a 14+ year relationship with Chase, the Chief Medical Officer of Checkmate Pharmaceuticals retained The Chase Group to identify a critical hire for…
Search Executed by The Chase Group, Inc. Results in Successful Appointment of Dr. Christophe Hotermans as SVP, Global Medical Affairs for Akcea Therapeutics
The Chase Group was once again retained by Akcea Therapeutics to complete an extensive executive search on an accelerated timeline for a Senior Vice President,…